Stay updated on Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page shows a new Revision: v3.4.2 and removes the prior operating-status notice (Revision: v3.4.1).
    Difference
    0.5%
    Check dated 2026-02-11T02:00:20.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Notice about government funding lapse and NIH Clinical Center status is now shown, and the page revision has been updated to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-03T23:13:23.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The changes are UI/UX updates (glossary toggle, color-coded change highlights, and revision notes) with no impact on actual study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1.0%
    Check dated 2026-01-28T00:13:56.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    A new revision label v3.3.4 was added and the previous v3.3.3 label removed in the page's Revision history; the main study details and history entries remain unchanged.
    Difference
    0.1%
    Check dated 2026-01-14T02:01:01.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Version 33 adds a new 'Study Status' entry to the Record History (dated 2025-12-23), replacing the prior 2025-11-19 entry.
    Difference
    0.3%
    Check dated 2025-12-30T22:37:12.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The history shows an addition of 'Revision: v3.3.3' and removals of 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' in the footer, which are site metadata updates rather than trial-specific content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T21:12:46.000Z thumbnail image

Stay in the know with updates to Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial page.